StatSoft Polska

StatSoft Polska Sp. z o.o. is a Polish analytics and software company based in Kraków. Its pharmaceutical offer combines statistical applications, product-lifecycle databases, custom systems, consulting and training. The company also distributes third-party analytics software.

The Polish company is distinct from the former US StatSoft business and StatSoft Europe. Official Polish registry records name ARONDIT GmbH as its sole shareholder. The founding instrument dates to 1995; registration in the current KRS register dates to 2003.

The pharmaceutical practice supplies quality monitoring, process and analytical-method validation, dissolution comparison, stability analysis, environmental statistics and measurement uncertainty. PLCS links development, validation and routine verification.

A vendor-hosted Adamed Pharma S.A. testimonial describes Statistica and dedicated validation, stability and dissolution applications. Current module versions are unconfirmed. Pharmaceutical customer counts and a current PLCS reference are unknown.

Revenue, profit, funding rounds and cash position are unknown. The official registry records filing of 2025 annual accounts on 18 June 2026. The filing does not establish financial strength. ARONDIT GmbH is the sole shareholder.

The catalogue covers PLCS and a grouped pharmaceutical-applications family: PQM, PV, DPC, AMV, PS, EM and MU. DPC has desktop and browser-based SaaS offers. Applications and optional database systems have different scopes. A single licence covering the whole family is unconfirmed.

Statistica, Spotfire, Jaspersoft, Alteryx and Power BI appear in the wider distributed software portfolio. Consulting and training are services. The current relationship between PLCS modules, desktop applications and custom databases needs confirmation.

The Spotfire partner directory lists StatSoft Polska for distribution and consulting. The company lists third-party analytics products in its portfolio. DPC SaaS uses Microsoft Azure according to the vendor. This hosting statement does not establish a Microsoft partner accreditation or the deployment of other products.

Services include pharmaceutical statistical consulting, tailored databases, implementation work and standard or customer-data training. The systems offer includes GMP design, testing and validation services. Included licence services, response times and 24-hour coverage are unknown. DPC cloud support follows its separate agreement.

The public team lists Piotr Wójtowicz as CEO, Grzegorz Migut as technical director and Michał Oczkowicz as software development manager. Pharmaceutical specialists include Marek Skowronek and Piotr Zawadzki. The company publishes product methods, examples and webinars.

Current scoped ISO certificates, SOC 2 reports, product analyst placements and independent product-review figures are unknown. Historical validated systems do not establish the controls of current applications.

Public Polish and English pages describe the pharmaceutical products. DPC cloud offers a 30-day trial. The Polish PQM page markets AI help with interpretation. A September 2026 stability webinar also discussed AI. Current released AI versions, licensing and validation scope remain unknown.